1036 / 1578
/
/
CONCLUSIONS
• Initial results are promising in terms of
o
Biochemical response / control
o
GI Toxicity
• Increased rates of GU toxicity
• Un-answered questions
o
Clinical patient selection factors : P-Vol, IPSS, …
o
OAR tolerance doses
o
Prophylactic / premedication: tamsulosin, steroids …
o
Role in intermediate and high risk patients
o
Toxicity and biochemical control with sufficient FU
Ø
Should be practiced within prospective protocols
Matthias Guckenberger - ESTRO SBRT Course 2017
27
07.09.17